Article content material
SUWA, Japan — Saint-Gobain Life Sciences at the moment introduced the addition of their Suwa, Japan manufacturing facility for the manufacturing of C-Flex® TPE tubing to be used in bioprocessing. The capability addition in Suwa is a part of Saint-Gobain Life Sciences ongoing funding plan to globally broaden manufacturing capability for its services used all through the bioprocessing trade.
Article content material
“The Suwa web site enlargement additional enhances our international manufacturing community, with a particular emphasis on supporting availability of our C-Flex® TPE tubing in Asia,” mentioned Benjamin Le Quéré, Bioprocess Options enterprise unit Common Supervisor at Saint-Gobain Life Sciences. “With the completion of Suwa’s functionality, we may have C-Flex® manufacturing capability in 5 separate amenities in 4 nations. This can be a distinctive functionality in TPE tubing for bioprocessing and it helps our mission to offer safety of provide.”
|
Web site Location |
Operational Standing |
|
Clearwater, FL USA |
Operational |
|
Charny, FRA |
Operational |
|
Largo, FL USA |
Operational |
|
Bangalore, IND |
Operational |
|
Suwa, JPN |
Deliberate This fall 2022 |
|
Hangzhou, CHN |
Deliberate Q1 2023 |
“We’ve got been making substantial progress on bettering C-Flex® service ranges and lead-times by means of Q2 of this 12 months,” mentioned Le Quéré. “The Suwa, Japan manufacturing capability being added in This fall and the addition of Hangzhou capability in early 2023 will additional strengthen our potential to satisfy the wants of the bioprocess trade.”
The C-Flex® manufacturing enlargement to the Saint-Gobain facility in Suwa, Japan is a part of a multi-year manufacturing technique, rising Bioprocess Options enterprise unit manufacturing capability across the globe, creating redundant manufacturing capabilities throughout Europe, North America, and Asia to help rising buyer demand.
The Saint-Gobain Suwa facility has been in operation since 1992 and employs roughly 100 staff, offering manufacturing functionality to a number of companies inside the Saint-Gobain Group.
About Saint-Gobain Life Sciences
Devoted to bettering the standard of life, Saint-Gobain Life Sciences develops and manufactures high-performance elements and built-in options that contact a broad vary of affected person care, from the event of recent therapeutic most cancers therapies to biopharmaceutical manufacturing, on by means of to intravenous therapies for drug supply. Combining our technical experience, international manufacturing capabilities and analysis and growth sources, Saint-Gobain Life Sciences is devoted to assembly the evolving wants of bioprocess, medical, and pharmaceutical clients world wide.
Saint-Gobain Life Sciences is a part of Saint-Gobain Group, a worldwide chief in gentle and sustainable development, which designs, manufactures, and distributes supplies and companies for the development and industrial markets.
€44.2 billion in gross sales in 2021
166,000 staff, situated in 75 nations
Dedicated to attaining Carbon Neutrality by 2050
For extra particulars on Saint-Gobain, go to: http://www.saint-gobain.com and comply with us on Twitter @saintgobain.
And go to: https://www.biopharm.saint-gobain.com
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20220615005135/en/
Contacts
Katy Oroszi
Saint-Gobain Life Sciences
Advertising and marketing Communications Supervisor
Katy.oroszi@saint-gobain.com
#distro
Article content material
SUWA, Japan — Saint-Gobain Life Sciences at the moment introduced the addition of their Suwa, Japan manufacturing facility for the manufacturing of C-Flex® TPE tubing to be used in bioprocessing. The capability addition in Suwa is a part of Saint-Gobain Life Sciences ongoing funding plan to globally broaden manufacturing capability for its services used all through the bioprocessing trade.
Article content material
“The Suwa web site enlargement additional enhances our international manufacturing community, with a particular emphasis on supporting availability of our C-Flex® TPE tubing in Asia,” mentioned Benjamin Le Quéré, Bioprocess Options enterprise unit Common Supervisor at Saint-Gobain Life Sciences. “With the completion of Suwa’s functionality, we may have C-Flex® manufacturing capability in 5 separate amenities in 4 nations. This can be a distinctive functionality in TPE tubing for bioprocessing and it helps our mission to offer safety of provide.”
|
Web site Location |
Operational Standing |
|
Clearwater, FL USA |
Operational |
|
Charny, FRA |
Operational |
|
Largo, FL USA |
Operational |
|
Bangalore, IND |
Operational |
|
Suwa, JPN |
Deliberate This fall 2022 |
|
Hangzhou, CHN |
Deliberate Q1 2023 |
“We’ve got been making substantial progress on bettering C-Flex® service ranges and lead-times by means of Q2 of this 12 months,” mentioned Le Quéré. “The Suwa, Japan manufacturing capability being added in This fall and the addition of Hangzhou capability in early 2023 will additional strengthen our potential to satisfy the wants of the bioprocess trade.”
The C-Flex® manufacturing enlargement to the Saint-Gobain facility in Suwa, Japan is a part of a multi-year manufacturing technique, rising Bioprocess Options enterprise unit manufacturing capability across the globe, creating redundant manufacturing capabilities throughout Europe, North America, and Asia to help rising buyer demand.
The Saint-Gobain Suwa facility has been in operation since 1992 and employs roughly 100 staff, offering manufacturing functionality to a number of companies inside the Saint-Gobain Group.
About Saint-Gobain Life Sciences
Devoted to bettering the standard of life, Saint-Gobain Life Sciences develops and manufactures high-performance elements and built-in options that contact a broad vary of affected person care, from the event of recent therapeutic most cancers therapies to biopharmaceutical manufacturing, on by means of to intravenous therapies for drug supply. Combining our technical experience, international manufacturing capabilities and analysis and growth sources, Saint-Gobain Life Sciences is devoted to assembly the evolving wants of bioprocess, medical, and pharmaceutical clients world wide.
Saint-Gobain Life Sciences is a part of Saint-Gobain Group, a worldwide chief in gentle and sustainable development, which designs, manufactures, and distributes supplies and companies for the development and industrial markets.
€44.2 billion in gross sales in 2021
166,000 staff, situated in 75 nations
Dedicated to attaining Carbon Neutrality by 2050
For extra particulars on Saint-Gobain, go to: http://www.saint-gobain.com and comply with us on Twitter @saintgobain.
And go to: https://www.biopharm.saint-gobain.com
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20220615005135/en/
Contacts
Katy Oroszi
Saint-Gobain Life Sciences
Advertising and marketing Communications Supervisor
Katy.oroszi@saint-gobain.com
#distro
